Research / UI / Fundamental state Inspectable configuration
State dimensions Filing 0001511737-24-000010 General Corporate
Debt relative to revenue 90th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
214.40% · OPTIONAL · VALID
Capex intensity 45th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
0.83% · OPTIONAL · VALID
Operating cash generation 35th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
16.90% · OPTIONAL · VALID
Revenue growth 20th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
-5.80% · CORE · VALID
Inventory pressure 90th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
147.02% · OPTIONAL · VALID
Gross margin 10th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
38.21% · CORE · VALID
Operating margin 10th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
26.05% · CORE · VALID
R&D intensity 85th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
7.94% · OPTIONAL · VALID
SBC intensity 100th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.32% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 60 states Self-history eligible
Sep 30, 2021 9/9 normalized Level 3 Dec 31, 2021 9/9 normalized Level 3 Mar 31, 2022 9/9 normalized Level 3 Jun 30, 2022 9/9 normalized Level 3 Sep 30, 2022 9/9 normalized Level 3 Dec 31, 2022 9/9 normalized Level 3 Mar 31, 2023 9/9 normalized Level 3 Jun 30, 2023 9/9 normalized Level 3 Sep 30, 2023 9/9 normalized Level 3 Dec 31, 2023 9/9 normalized Level 3 Mar 31, 2024 9/9 normalized Level 3 Jun 30, 2024 9/9 normalized Level 3 Sep 30, 2024 9/9 normalized Level 3 Dec 31, 2024 9/9 normalized Level 3 Mar 31, 2025 9/9 normalized Level 3 Jun 30, 2025 9/9 normalized Level 3 Sep 30, 2025 9/9 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 8/8 normalized Level 3 Jun 30, 2026 8/8 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 225.93%
Current 214.40%
Delta -11.53% Capex Intensity Increased
Previous 0.65%
Current 0.83%
Delta 0.18% Cash Generation Increased
Previous 14.62%
Current 16.90%
Delta 2.29% Growth Increased
Previous -7.03%
Current -5.80%
Delta 1.23% Inventory Pressure Decreased
Previous 152.57%
Current 147.02%
Delta -5.54% Margin Decreased
Previous 39.71%
Current 38.21%
Delta -1.50% Profitability Decreased
Previous 27.71%
Current 26.05%
Delta -1.66% R And D Intensity Increased
Previous 7.84%
Current 7.94%
Delta 0.10% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.